secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2025-08-21T23:59:59+00:00
Accession:  0001104659-25-081419
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio prices $50M public offering of pre-funded warrants and Series G/H warrants
-------------------------------------------------------------------------------

- Combined offering price $0.699 per unit; gross proceeds ~$50M before underwriting discounts and expenses.
- Pre-funded warrants exercisable immediately at $0.001; Series G warrants at $0.70 expire upon trial initiation milestone or 5 years.
- Series H warrants expire 4 years after closing; total potential additional proceeds of ~$50M if all warrants exercised for cash.
- Net proceeds to advance preclinical cardiometabolic programs IBIO-610 (myostatin/activin A bispecific) and IBIO-600.
- Closing expected August 22, 2025; 90-day lock-up on share issuance for company and insiders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000110465925081419/0001104659-25-081419-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000110465925081419/tm2523907d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-081419

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer